Revance Therapeutics, Inc. Gains 54.34%
Revance Therapeutics, Inc. (RVNC:NASDAQ) jumped higher at $30.42, representing a gain of 54.3%. On Mon, Jan 09, 2023, RVNC:NASDAQ touched a New 2-Week High of $30.42. The stock appeared on our News Catalysts scanner on Mon, Jan 09, 2023 at 09:29 AM in the 'INVESTOR UPDATE' category. From Tue, Dec 27, 2022, the stock recorded 50.00% Up Days and 66.67% Green Days
The stock spiked on Fri, Oct 07, 2022 at $30.95 with a volume of 1M+.
About Revance Therapeutics, Inc. (RVNC:NASDAQ)
Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
Top 10 Gainers:
- CinCor Pharma Inc. (CINC:NASDAQ), 143.97%
- Amryt Pharma plc (AMYT:NASDAQ), 106.99%
- Albireo Pharma, Inc. (ALBO:NASDAQ), 92.16%
- Apexigen Inc Com (APGN:NASDAQ), 91.49%
- Revance Therapeutics, Inc. (RVNC:NASDAQ), 54.34%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 52.86%
- Duck Creek Technologies Inc. (DCT:NASDAQ), 46.5%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 42.39%
- Ebang International Holdings Inc. (EBON:NASDAQ), 40.72%
- Greenidge Generation Holdings Inc. (GREE:NASDAQ), 37.9%